Insights: Results
Initial Data Shows that PTAB Is Not a ῾Death Squadʼ for Biologic Drug Patents
by Corinne E. Atton and April M. Breyer
The March 2017 statistics issued by PTAB report that across all technologies, all challenged patent claims are found patentable in only 19 percent of inter partes review (IPR) final written decisions.
New European Unitary Patent Is Not-So-Wonderful
by Michael B. Fein
If the European Parliament and the 25 participating states were trying to emulate a U.S. patent and replace the present Balkanized system wherein each state has its own patent granting authority and courts handling patent litigation, it has failed miserably.
Sorry, no results were found.
Suggestions:
- Check your spelling.
- Try more general words.
- Try a different word with the same meaning.